Amedeo Smart

Free Medical Literature Service

 

Amedeo

Rheumatoid Arthritis
  Free Subscription

Articles published in
J Rheumatol
    September 2025
  1. ESTER M, Dhiman K, Githumbi R, Sipley M, et al
    Priority Setting of Physical Activity Barriers and Facilitators Among Individuals With Rheumatoid Arthritis: A Nominal Group Technique Study.
    J Rheumatol. 2025 Sep 15:jrheum.2025-0191.C1. doi: 10.3899/jrheum.2025-0191.
    >> Share

  2. JOERNS EK, Lopez-Ruiz A, Lennon RJ, Crowson CS, et al
    Differences in Cause-Specific Mortality in Patients with Rheumatoid Arthritis by Sex and Seropositivity.
    J Rheumatol. 2025 Sep 15:jrheum.2025-0361. doi: 10.3899/jrheum.2025-0361.
    >> Share

  3. BANINA MC, Prabhune R, Charles C, Colmegna I, et al
    Understanding patient and physician perspectives regarding innovative research in rheumatoid arthritis.
    J Rheumatol. 2025 Sep 15:jrheum.2025-0510. doi: 10.3899/jrheum.2025-0510.
    >> Share

  4. KHIDIR SJH, van Mulligen E, van der Helm-van Mil AHM
    Identifying resolution of clinically suspect arthralgia: a step towards understanding spontaneous reversal of an at-risk stage of rheumatoid arthritis.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0052. doi: 10.3899/jrheum.2025-0052.
    >> Share

  5. BARDAN I, Uhlig T, Sexton J, Kvien TK, et al
    Health-related Quality of Life in DMARD-treated adults with Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0384. doi: 10.3899/jrheum.2025-0384.
    >> Share

  6. BEYDON M, Nguyen Y, Gordon R, Foulquier N, et al
    A Systematic Review of Clinical Trial Designs and Outcome Measures in Sjogren Disease Randomized Controlled Trials.
    J Rheumatol. 2025;52:858-872.
    >> Share

    August 2025
  7. SAUVE E, Barnabe C
    The Usual Suspects: Established and Emerging Predictor Variables for Remission in Rheumatoid Arthritis.
    J Rheumatol. 2025 Aug 15:jrheum.2025-0476. doi: 10.3899/jrheum.2025-0476.
    >> Share

  8. YAMADA S, Azuma T
    Multiple Hematoma, Purpura, and Ulcers in a Patient With Rheumatoid Arthritis.
    J Rheumatol. 2025 Aug 1:jrheum.2025-0516. doi: 10.3899/jrheum.2025-0516.
    >> Share

  9. TOUSSIROT E, Ramon A, Laheurte C, Gravelin E, et al
    Analysis of Gut-Homing Receptors in Circulating Mucosal-Associated Invariant T Cells and Their Presence in Synovial Tissue From Patients With Axial Spondyloarthritis.
    J Rheumatol. 2025;52:770-778.
    >> Share

    July 2025
  10. BROOKS RT, Hulshizer CA, Hanson AC, Davis JM 3rd, et al
    Cumulative Incidence of Cancer Screening for Breast, Cervical, Prostate, and Colorectal Cancer in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0190. doi: 10.3899/jrheum.2025-0190.
    >> Share

  11. ESTER M, Dhiman K, Githumbi R, Sipley M, et al
    Priority setting of physical activity barriers and facilitators among individuals with rheumatoid arthritis: a nominal group technique study.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0191. doi: 10.3899/jrheum.2025-0191.
    >> Share

  12. LAI SW
    Herpes Zoster Vaccine and Rheumatoid Arthritis.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0272. doi: 10.3899/jrheum.2025-0272.
    >> Share

  13. TAMAI H, Ito S, Takanashi S, Kondo Y, et al
    Achievement and Usefulness of Intermediate Treatment Targets for Still Disease Proposed by the European Alliance of Associations for Rheumatology and the Paediatric Rheumatology European Society.
    J Rheumatol. 2025;52:662-668.
    >> Share

  14. GAMA CR, Franco AS, Bortoluzzo AB, Miossi R, et al
    Characteristics of Overlap Syndrome in a Large Cohort of Brazilian Patients With Systemic Sclerosis: A Retrospective Analysis.
    J Rheumatol. 2025;52:693-698.
    >> Share

    June 2025
  15. SUKKAR MB, Ainley R, Barrett C, Bond S, et al
    Development of the Australian Rheumatology Association Clinical Care Standard for the diagnosis and management of rheumatoid arthritis in adults.
    J Rheumatol. 2025 Jun 1:jrheum.2024-1034. doi: 10.3899/jrheum.2024-1034.
    >> Share

    May 2025
  16. GJERTSSON I, Aurell Y, Rudin A, Hultgard Ekwall AK, et al
    Cone beam computed tomography for assessment of erosions in early rheumatoid arthritis - a pilot study.
    J Rheumatol. 2025 May 15:jrheum.2024-1276. doi: 10.3899/jrheum.2024-1276.
    >> Share

  17. PATTERSON SL, Ruvalcaba D, Issa A, Rai K, et al
    Experiences with Complementary and Integrative Health Among People with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study.
    J Rheumatol. 2025 May 1:jrheum.2024-1218. doi: 10.3899/jrheum.2024-1218.
    >> Share

  18. KOPPIKAR S, Kuriya B, Udell JA, Yu B, et al
    Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study.
    J Rheumatol. 2025;52:489-497.
    >> Share

    April 2025
  19. RAZMJOU AA, Pham A, Volkmann ER, Ranganath VK, et al
    Survival After Lung Transplantation in Patients With Rheumatoid Arthritis-Associated Lung Disease.
    J Rheumatol. 2025 Apr 15:jrheum.2025-0025. doi: 10.3899/jrheum.2025-0025.
    >> Share

  20. GITHUMBI R, Katz SJ, Widdifield J, Barber CEH, et al
    Update to a Systematic Review on Quality Measures for Rheumatoid Arthritis.
    J Rheumatol. 2025 Apr 15:jrheum.2024-1314. doi: 10.3899/jrheum.2024-1314.
    >> Share

  21. KELLY CA, Shaikh M
    Practical Issues Relating to the Use of Antifibrotic Therapy in Patients With Interstitial Lung Disease and Rheumatoid Arthritis.
    J Rheumatol. 2025 Apr 1:jrheum.2025-0103. doi: 10.3899/jrheum.2025-0103.
    >> Share

  22. SINGH JA, Chandrupatla SR
    Rural-dwelling patients with rheumatoid arthritis have higher risk of myocardial infarction hospitalization: an observational study using the National Inpatient Sample.
    J Rheumatol. 2025 Apr 1:jrheum.2024-1036. doi: 10.3899/jrheum.2024-1036.
    >> Share

    March 2025
  23. KOC GH, Looijen AEM, van der Horst-Bruinsma IE, de Jong PHP, et al
    Sex Differences in Rheumatoid Arthritis: New Insights from clinical and patient-reported outcome perspective.
    J Rheumatol. 2025 Mar 1:jrheum.2024-1258. doi: 10.3899/jrheum.2024-1258.
    >> Share

  24. MOVAHEDI M, Cesta A, Li X, Tatangelo M, et al
    Health Care Utilization and Cost of Herpes Zoster Infection in Patients with Rheumatoid Arthritis, a Retrospective Cohort Study.
    J Rheumatol. 2025 Mar 1:jrheum.2024-0911. doi: 10.3899/jrheum.2024-0911.
    >> Share

  25. WANG G, Liu Z
    Association Between Rheumatoid Arthritis and Ambulatory Blood Pressure.
    J Rheumatol. 2025 Mar 1:jrheum.2024-1292. doi: 10.3899/jrheum.2024-1292.
    >> Share

  26. ROUMEN C, Hochstenbach LM, van den Dungen P, Knops AM, et al
    Development of an application for self-monitoring to empower patients with rheumatoid arthritis (MyRA).
    J Rheumatol. 2025 Mar 1:jrheum.2024-1071. doi: 10.3899/jrheum.2024-1071.
    >> Share

  27. LOVGACH OR, Plaza Z, Castro MF, Rosas J, et al
    Mortality in Patients With Sjogren Disease: A Prospective Cohort Study Identifying Key Predictors.
    J Rheumatol. 2025;52:257-262.
    >> Share

    February 2025
  28. CAPELUSNIK D, Ramiro S, Nikiphorou E, Maksymowych WP, et al
    Unacceptable work state in rheumatoid arthritis: establishment of thresholds for presenteeism and clinical measurement instruments.
    J Rheumatol. 2025 Feb 1:jrheum.2024-0833. doi: 10.3899/jrheum.2024-0833.
    >> Share

  29. ROJAS-SERRANO J
    Progressive Pulmonary Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    J Rheumatol. 2025 Feb 1:jrheum.2024-1333. doi: 10.3899/jrheum.2024-1333.
    >> Share

    January 2025
  30. CHANG SH, Park YB, McDermott GC, Paudel ML, et al
    Serum Biomarkers of Pulmonary Damage and Risk for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0713. doi: 10.3899/jrheum.2024-0713.
    >> Share

  31. EDWARDS CJ, Kronke G, Avouac J, Li Z, et al
    Baricitinib dose reduction in patients with rheumatoid arthritis achieving sustained disease control: Final results from the RA-BEYOND study.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0906. doi: 10.3899/jrheum.2024-0906.
    >> Share

  32. EMERY P, Fleischmann R, Wong R, Lozenski K, et al
    Association between abatacept exposure levels and infection occurrence in patients with rheumatoid arthritis: post hoc analysis of the AVERT-2 study.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0498. doi: 10.3899/jrheum.2024-0498.
    >> Share

  33. CASO F, Giacomelli R, Nunziato M, Di Maggio F, et al
    The Reshaping of Modifiable Risk Factors as a Strategy to Prevent the Development of Rheumatoid Arthritis.
    J Rheumatol. 2025 Jan 15:jrheum.2024-0545. doi: 10.3899/jrheum.2024-0545.
    >> Share

  34. SWEET N, Huang H, Bartels CM
    Mind Matters in Rheumatoid Arthritis: The Rising Burden of Anxiety and Depression.
    J Rheumatol. 2025 Jan 15:jrheum.2024-1273. doi: 10.3899/jrheum.2024-1273.
    >> Share

    December 2024
  35. SEBASTIANI M, Lepri G, Iannone C, Cassione EB, et al
    Nintedanib in rheumatoid arthritis related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation.
    J Rheumatol. 2024 Dec 15:jrheum.2024-0976. doi: 10.3899/jrheum.2024-0976.
    >> Share

  36. WANG G, Liu Z
    High-Sensitivity Cardiac Troponin T as a Marker to Improve Cardiovascular Disease Risk Assessment Among Patients With Rheumatoid Arthritis.
    J Rheumatol. 2024 Dec 15:jrheum.2024-0723. doi: 10.3899/jrheum.2024-0723.
    >> Share

  37. HITCHON CA, El-Gabalawy HS
    Rheumatoid Arthritis Treatment Has Changed Dramatically Over the Past 3 Decades, but Has the Disease Itself Changed?
    J Rheumatol. 2024 Dec 15:jrheum.2024-1160. doi: 10.3899/jrheum.2024-1160.
    >> Share

  38. NOSSENT J, Keen HI, Preen DB, Inderjeeth CA, et al
    Cancer incidence and outcome for patients with Rheumatoid Arthritis: a long-term population study in Western Australia.
    J Rheumatol. 2024 Dec 15:jrheum.2024-0724. doi: 10.3899/jrheum.2024-0724.
    >> Share

  39. LEONG KP, Yong MY, Koh ET, Cheung PPM, et al
    Exome sequencing of Singapore Chinese anti-citrullinated-protein-antibody-positive rheumatoid arthritis patients.
    J Rheumatol. 2024 Dec 1:jrheum.2024-0140. doi: 10.3899/jrheum.2024-0140.
    >> Share

  40. LEE YC, Malfait AM, Ogdie AR
    Unmet Needs in Spondyloarthritis: Understanding and Managing Chronic Pain.
    J Rheumatol. 2024;51:1235-1240.
    >> Share

  41. DEANE KD, Donlin LT, Ritchlin CT, Kuhn KA, et al
    Are There Disease Endotypes in Axial Spondyloarthritis and How Would We Define Them?
    J Rheumatol. 2024;51:1229-1234.
    >> Share

    November 2024
  42. SUGAWARA E, Ninagawa K, Katsumata K
    Infected Tumoral Calcinosis Associated With Rheumatoid Arthritis.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0761. doi: 10.3899/jrheum.2024-0761.
    >> Share

  43. PROVAN SA, Ljung L, Kristianslund EK, Michelsen B, et al
    Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic Registries.
    J Rheumatol. 2024;51:1111-1118.
    >> Share

    October 2024
  44. GIBLON RE, Achenbach SJ, Myasoedova E, Davis JM 3rd, et al
    Rising? trends in Anxiety and Depression among Individuals with Rheumatoid Arthritis: A Population-Based Study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0165. doi: 10.3899/jrheum.2024-0165.
    >> Share

  45. RYDHOLM M, Hagel S, Jacobsson LTH, Turesson C, et al
    Disability Related to the Upper Extremities in Early Rheumatoid Arthritis - Long-term Course and Disease Parameter Impact: a cohort study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0608. doi: 10.3899/jrheum.2024-0608.
    >> Share

  46. YANG T, Soto Gamez AA, Terpstra JH, Bootsma H, et al
    Cell Composition Analysis of Matched Salivary Organoid and Adherent Cultures: Choose Your Sjogren Disease Research Tool Carefully.
    J Rheumatol. 2024;51:1044-1046.
    >> Share

  47. PIANAROSA E, Roach P, Barber CEH, Holroyd BR, et al
    Deciding to Attend the Emergency Department: Experiences of Patients With Inflammatory Arthritis.
    J Rheumatol. 2024;51:1015-1022.
    >> Share

    September 2024
  48. CARRIER N, Roux S, Masetto A, De Brum Fernandes AJ, et al
    Early Rheumatoid Arthritis Patients at Presentation Are Changing: A 24-Year Study of the Early Undifferentiated PolyArthritis (EUPA) Cohort.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0560. doi: 10.3899/jrheum.2024-0560.
    >> Share

  49. LIU S, Hu R
    Evaluating and Refining Strategies for Rheumatoid Arthritis Prevention in First Nations Communities.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0726. doi: 10.3899/jrheum.2024-0726.
    >> Share

    August 2024
  50. LEE J, Barber C, Jung M, Kaminska E, et al
    Decision Aid-Led Tapering of Biologic and Targeted Synthetic DMARDs in Rheumatoid Arthritis: A Qualitative Study.
    J Rheumatol. 2024 Aug 15:jrheum.2024-0383. doi: 10.3899/jrheum.2024-0383.
    >> Share

  51. RODRIGUEZ-GONZALEZ D, Garcia-Gonzalez M, Gomez-Bernal F, Quevedo-Abeledo JC, et al
    Understanding the role of the complement system in insulin resistance and metabolic syndrome in patients with rheumatoid arthritis.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0437. doi: 10.3899/jrheum.2024-0437.
    >> Share

  52. MORRISON T, Gottman M, Do T, Rosenbaum JT, et al
    Scleritis and Development of Immune-Mediated Disease: A Retrospective Chart Review.
    J Rheumatol. 2024;51:825-830.
    >> Share

    July 2024
  53. NIKOLIC RPA, Pardo Pardo J, Pope JE, Barber CEH, et al
    Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #2.
    J Rheumatol. 2024 Jul 15:jrheum.2024-0540. doi: 10.3899/jrheum.2024-0540.
    >> Share

  54. EL-GABALAWY H
    The Impact of Rheumatoid Arthritis on First Nations and How We Can Work With Communities to Prevent It.
    J Rheumatol. 2024;51.
    >> Share

  55. TAYLOR PC
    The Rheumatoid Arthritis Impact of Disease (RAID) Score in Telemedicine Management of Rheumatoid Arthritis.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0579. doi: 10.3899/jrheum.2024-0579.
    >> Share

  56. VASSILAKI M, Jose George R, Kumar R, Lovering E, et al
    Validation of Different Dementia Code-based Definitions in a Population-based Study of Rheumatoid Arthritis.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0299. doi: 10.3899/jrheum.2024-0299.
    >> Share

  57. TARANNUM S, Widdifield J, Wu CF, Johnson SR, et al
    Sex-Related Differences in Dispensation of Rheumatic Medications in Older Patients With Inflammatory Arthritis: A Population-Based Study.
    J Rheumatol. 2024;51:703-707.
    >> Share

  58. VISSER A, van Nimwegen JF, Wilbrink R, Liefers SC, et al
    Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjogren Syndrome.
    J Rheumatol. 2024;51:687-695.
    >> Share

    June 2024
  59. WEBER BN, Weisenfeld D, Jeffway M, Liu F, et al
    The Association Between High-Sensitivity Cardiac Troponin T and Major Adverse Cardiovascular Events in Rheumatoid Arthritis.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0168. doi: 10.3899/jrheum.2024-0168.
    >> Share

  60. AVOUAC J, Molto A, Allanore Y
    Evaluation of the RAID Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation.
    J Rheumatol. 2024 Jun 1:jrheum.2024-0143. doi: 10.3899/jrheum.2024-0143.
    >> Share

  61. SUBDAR S, Dhiman K, Hartfeld NMS, Hoens AM, et al
    Investigating the Influence of Patient Eligibility Characteristics on the Number of Deferrable Rheumatologist Visits: Planning for a Patient-Initiated Follow-Up Strategy.
    J Rheumatol. 2024;51:587-595.
    >> Share

    May 2024
  62. SMITH ID, Solomon MJ, Mulder H, Sims C, et al
    Evaluating factors associated with telehealth appropriateness in outpatient rheumatoid arthritis encounters using the Encounter Appropriateness Score for You (EASY).
    J Rheumatol. 2024 May 15:jrheum.2024-0014. doi: 10.3899/jrheum.2024-0014.
    >> Share

  63. ORMSETH MJ, Oeser AM, Chung CP, Stein CM, et al
    Ambulatory blood pressure in patients with rheumatoid arthritis: association with immune activation.
    J Rheumatol. 2024 May 15:jrheum.2024-0205. doi: 10.3899/jrheum.2024-0205.
    >> Share

  64. RYDELL E, Jacobsson LTH, Turesson C
    Circulating interleukin 17A and other inflammatory proteins may predict cardiovascular disease in early rheumatoid arthritis.
    J Rheumatol. 2024 May 1:jrheum.2023-1078. doi: 10.3899/jrheum.2023-1078.
    >> Share

  65. EL-GABALAWY H
    The Impact of Rheumatoid Arthritis on First Nations and How We Can Work With Communities to Prevent It.
    J Rheumatol. 2024 May 1:jrheum.2024-0369. doi: 10.3899/jrheum.2024-0369.
    >> Share

  66. MITTINTY MM, Mittinty MN, Buchbinder R, Lassere M, et al
    Interpersonal process of dyadic coping in rheumatoid arthritis: a perspective from the Australian Rheumatology Association Database (ARAD).
    J Rheumatol. 2024 May 1:jrheum.2023-0664. doi: 10.3899/jrheum.2023-0664.
    >> Share

  67. RUSCITTI P, McGonagle D, Garcia VC, Rabijns H, et al
    Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs.
    J Rheumatol. 2024;51:442-451.
    >> Share

    April 2024
  68. BURMESTER GR, Van den Bosch F, Tesser J, Shmagel A, et al
    Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
    J Rheumatol. 2024 Apr 15:jrheum.2023-1062. doi: 10.3899/jrheum.2023-1062.
    >> Share

  69. RAMSAY D, Taylor T
    Does Changing Anticyclic Citrullinated Protein Testing From Restricted Ordering to Open Ordering Affect Healthcare Utilization and the Rate of Positive Testing?
    J Rheumatol. 2024;51:432-433.
    >> Share

  70. EVIATAR T, Furer V, Polachek A, Zisman D, et al
    Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.
    J Rheumatol. 2024;51:415-422.
    >> Share

    March 2024
  71. SUBDAR S, Hoens AM, White K, Hartfeld NMS, et al
    An environmental scan and appraisal of patient online resources for managing rheumatoid arthritis flares.
    J Rheumatol. 2024 Mar 15:jrheum.2023-1025. doi: 10.3899/jrheum.2023-1025.
    >> Share

  72. WIENS D, Smolik IA, MacKay D, Fowler-Woods A, et al
    Perceived Access to Health Care of Indigenous Peoples in Canada with Rheumatoid Arthritis and their First-Degree Relatives.
    J Rheumatol. 2024 Mar 1:jrheum.2023-1080. doi: 10.3899/jrheum.2023-1080.
    >> Share

  73. FONG KTD, Sng WJ, Lee KMV, Tan HSA, et al
    A Familiar Face in an Unfamiliar Place: Intraosseous Rheumatoid Nodule.
    J Rheumatol. 2024;51:314-315.
    >> Share

    February 2024
  74. PAPPAS DA, O'Brien J, Moore PC, Dodge R, et al
    Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results from the CorEvitas Rheumatoid Arthritis Registry.
    J Rheumatol. 2024 Feb 15:jrheum.2023-0752. doi: 10.3899/jrheum.2023-0752.
    >> Share

  75. WIERCZEIKO A, Linke M, Friedrich JP, Koch J, et al
    A Call for Gene Expression Analysis in Whole Blood of Patients With Rheumatoid Arthritis (RA) as a Biomarker for RA-Associated Interstitial Lung Disease.
    J Rheumatol. 2024;51:130-133.
    >> Share

  76. KRISTENSEN S, Hagelskjaer AM, Cordtz R, Bliddal S, et al
    Polyautoimmunity in patients with anti-cyclic citrullinated peptide antibody-positive and -negative rheumatoid arthritis: a nationwide cohort study from Denmark.
    J Rheumatol. 2024 Feb 1:jrheum.2023-0907. doi: 10.3899/jrheum.2023-0907.
    >> Share

  77. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis.
    J Rheumatol. 2024 Feb 1:jrheum.2023-1210. doi: 10.3899/jrheum.2023-1210.
    >> Share

  78. HEMGREN C, Martinsson K, Rooney C, Wettero J, et al
    Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis.
    J Rheumatol. 2024;51:134-138.
    >> Share

  79. FARRER C, Thib S, Eder L, Jerome D, et al
    Use of Coordinator Role Improves Access to Rheumatologic Advanced Therapy.
    J Rheumatol. 2024;51:197-202.
    >> Share

    January 2024
  80. O'NEIL LJ, Alpizar-Rodriguez D, Deane KD
    Rheumatoid arthritis: The continuum of disease and strategies for prediction, early intervention and prevention.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0334. doi: 10.3899/jrheum.2023-0334.
    >> Share

  81. STAMP LK, Keating P, Frampton C, Barclay ML, et al
    Relationship between adalimumab concentrations, anti-drug antibodies and disease activity in rheumatoid arthritis: a cross-sectional observational study.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0706. doi: 10.3899/jrheum.2023-0706.
    >> Share

  82. LUO P, Xu W, Ye D, Chen W, et al
    Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0349. doi: 10.3899/jrheum.2023-0349.
    >> Share

    December 2023
  83. ZHUO N, Wang G, Wu G
    The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Dec 1:jrheum.2023-0249. doi: 10.3899/jrheum.2023-0249.
    >> Share

    November 2023
  84. POSIO C, Suardi I, Caporali R, Ingegnoli F, et al
    Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Nov 15:jrheum.2023-0950. doi: 10.3899/jrheum.2023-0950.
    >> Share

  85. NOWELL WB, Barnes EL, Venkatachalam S, Kappelman MD, et al
    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network.
    J Rheumatol. 2023;50:1503-1508.
    >> Share

  86. MURAYAMA A
    Industry-Sponsored Research Funding to Rheumatologists in the United States Between 2014 and 2022.
    J Rheumatol. 2023;50:1510-1513.
    >> Share

  87. INANC N, Jousse-Joulin S, Abacar K, Cimsit C, et al
    The novel OMERACT Ultrasound Scoring System for salivary glands changes in patients with Sjogren's syndrome is associated with MRI and salivary flow rates.
    J Rheumatol. 2023 Nov 1:jrheum.2023-0202. doi: 10.3899/jrheum.2023-0202.
    >> Share

    October 2023
  88. KWON HC, Kang MI, Kim SM
    Cystatin C as a Predictor of Renal function and Methotrexate-associated toxicities in Patients with Rheumatoid arthritis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0218. doi: 10.3899/jrheum.2023-0218.
    >> Share

  89. LEE JJY, Bernatsky S, Kwong JC, Li Q, et al
    Safety and Health Care Utilization following COVID-19 Vaccination among Adults with Rheumatoid Arthritis - A population-based self-controlled case series analysis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0355. doi: 10.3899/jrheum.2023-0355.
    >> Share

  90. KWOK TSH, Kuriya B, Eder L, Aghanya V, et al
    Low Nirmatrelvir/Ritonavir Use Among Patients With Rheumatoid Arthritis: A Signal of Concern.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0439. doi: 10.3899/jrheum.2023-0439.
    >> Share

  91. CHANG YH, Buras MR, Davis JM 3rd, Crowson CS, et al
    Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated Measures.
    J Rheumatol. 2023;50:1269-1272.
    >> Share

  92. ISLAM ST, Descallar J, Martens D, Hassett G, et al
    Screening for Anxiety in Patients With Inflammatory Arthritis Using the Multidimensional Health Assessment Questionnaire.
    J Rheumatol. 2023;50:1273-1278.
    >> Share

  93. SHRIDHARMURTHY D, Lapane KL, Nunes AP, Baek J, et al
    Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study.
    J Rheumatol. 2023;50:1287-1295.
    >> Share

    September 2023
  94. BARTON JL
    Unequal Treatment: Physical Therapy Utilization in Rheumatoid Arthritis.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0814. doi: 10.3899/jrheum.2023-0814.
    >> Share

  95. VISMAN I, Atiqi S, Boers M, Twisk J, et al
    Changes in TNF inhibitor drug survival in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis over 15 years.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0149. doi: 10.3899/jrheum.2023-0149.
    >> Share

  96. BRYNJARSDOTTIR HB, Bjursten S, Levin M, Gjertsson I, et al
    Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment.
    J Rheumatol. 2023;50:1195-1197.
    >> Share

  97. YAMAMOTO K, Rokutanda R
    Disseminated Mycobacterium haemophilum Infection Mimicking Rheumatoid Nodules.
    J Rheumatol. 2023;50:1193.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016